A retrospective review of sedation of lizards using dexmedetomidine-midazolam (DM) with or without ketamine administered intramuscularly or subcutaneously was performed. Forty-four sedation events, involving 25 individuals and 16 different species of lizards, were reviewed. Sedation was performed for physical examinations, imaging, biopsy collection, and wound treatments. Dexmedetomidine (median: 0.08 mg/kg, 25–75%: 0.05–0.1 mg/kg, range: 0.03–0.3 mg/kg) combined with midazolam (median: 1 mg/kg, 25–75%: 0.85–1 mg/kg, range: 0.5–2 mg/kg) was used in 11/44 (25%) sedation events. In 33/44 (75%) sedation events, ketamine (median: 2.9 mg/kg, 25–75%: 2.43–3 mg/kg range: 0.9–5 mg/kg) was administered in addition to DM. Insufficient depth of sedation was reported for 2/44 (4.5%) events. Atipamezole (10 times the milligrams dose of dexmedetomidine) and flumazenil (median: 0.05 mg/kg, 25–75%: 0.05–0.05 mg/kg, range: 0.01–0.1 mg/kg) were administered for reversal of the sedative effects of DM in all sedation events. The most common complication noted was apnea, which occurred in 2/44 (4.5%) sedation events and resolved following administration of the reversal agents.
How to translate text using browser tools
1 January 2018
Retrospective Evaluation of Sedation in 16 Lizard Species with Dexmedetomidine-Midazolam with or without Ketamine
Lucas Budden,
Grayson A. Doss,
Victoria L. Clyde,
Christoph Mans
ACCESS THE FULL ARTICLE
It is not available for individual sale.
This article is only available to subscribers.
It is not available for individual sale.
It is not available for individual sale.
analgesia
Anesthesia
Chemical restraint
immobilization
reptiles
Squamata